Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahil Rao

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell Reports. Medicine|August 8, 2023
High-dimensional profiling of pediatric immune responses to solid organ transplantationMahil Rao, Meelad Amouzgar, James T Harden, et al.
Shock (Augusta, Ga.)|May 16, 2024
TEMPORAL CHANGES IN INNATE AND ADAPTIVE IMMUNITY DURING SEPSIS AS DETERMINED BY ELISPOTJacqueline Unsinger, Dale Osborne, Andrew H Walton, et al.
Shock (Augusta, Ga.)|October 30, 2025
Quantifying Nuance within Sepsis-Associated Immune Suppression toward Diagnostic CertaintyCharles C Caldwell, Robert Maile, Monty B Mazer, et al.
Journal of Immunological Methods|August 15, 2024
Development and optimization of a diluted whole blood ELISpot assay to test immune functionRicardo F Ungaro, Julie Xu, Tamara A Kucaba, et al.
Frontiers in Immunology|October 28, 2022
Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative DisorderAyantika Sen, Jeanna Enriquez, Mahil Rao, et al.
Frontiers in Immunology|October 29, 2024
Surviving septic patients endotyped with a functional assay demonstrate active immune responsesAdam D Price, Ellen R Becker, Evan L Barrios, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational StudyEvan A Barrios, Monty B Mazer, Patrick McGonagill, et al.
JCI Insight|December 15, 2023
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpotEvan L Barrios, Monty B Mazer, Patrick W McGonagill, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Reports. Medicine|August 8, 2023
High-dimensional profiling of pediatric immune responses to solid organ transplantationMahil Rao, Meelad Amouzgar, James T Harden, et al.
Shock (Augusta, Ga.)|May 16, 2024
TEMPORAL CHANGES IN INNATE AND ADAPTIVE IMMUNITY DURING SEPSIS AS DETERMINED BY ELISPOTJacqueline Unsinger, Dale Osborne, Andrew H Walton, et al.
Shock (Augusta, Ga.)|October 30, 2025
Quantifying Nuance within Sepsis-Associated Immune Suppression toward Diagnostic CertaintyCharles C Caldwell, Robert Maile, Monty B Mazer, et al.
Journal of Immunological Methods|August 15, 2024
Development and optimization of a diluted whole blood ELISpot assay to test immune functionRicardo F Ungaro, Julie Xu, Tamara A Kucaba, et al.
Frontiers in Immunology|October 28, 2022
Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative DisorderAyantika Sen, Jeanna Enriquez, Mahil Rao, et al.
Frontiers in Immunology|October 29, 2024
Surviving septic patients endotyped with a functional assay demonstrate active immune responsesAdam D Price, Ellen R Becker, Evan L Barrios, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational StudyEvan A Barrios, Monty B Mazer, Patrick McGonagill, et al.
JCI Insight|December 15, 2023
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpotEvan L Barrios, Monty B Mazer, Patrick W McGonagill, et al.
Pageof 2